Middle East & Africa Fluorescent Immunoassay Market Forecast to 2028

Report Code : BMIRE00025663 | Region : LAMEA | Industry : Biotechnology | Published Date : 10/Aug/2022
Middle East & Africa Fluorescent Immunoassay Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (ELISA, Rapid Lateral Flow Immunoassay, and Others), Application (Infectious Diseases, Oncology, Cardiovascular Diseases, and Others), and End User (Hospitals & Clinics, Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others)

The MEA fluorescent immunoassay market is expected to grow from US$ 91.36 million in 2021 to US$ 109.74 million by 2028; it is estimated to grow at a CAGR of 2.7% from 2021 to 2028.

Human blood is an essential medical detection index. With the development of clinical medical detection instruments and detection technologies, the requirements for detection accuracy and efficiency have been gradually improved. Early diagnosis and complete surgical resection offer the best prospects for curative cancer treatment. Fluorescence immunochromatography is a new detection technique. It is characterized by high efficiency, convenience, no pollution, and a large detection area. Human blood can be rapidly detected using fluorescent immunochromatography. The concentration of pathogenic factors (cancer cells) in human serum can be conveniently and accurately measured. The system integrates many peripheral modules, including fluorescence signal acquisition, processing, quantitative curve fitting, and test results. The translation of laboratory science into effective clinical cancer therapy is growing significantly. Understanding cancer cell surface receptors, cancer cell growth, and cancer metabolic pathways have led to many promising molecularly targeted therapies and cancer gene therapies. In the laboratory setting, fluorescence imaging (FI) and bioluminescence imaging (BLI) has long been used in preclinical research to quantify tumor mass, assess tumor targeting by experimental drugs, and distinguish between primary and secondary effects of cancer treatments. Many cancers, including breast, colon, and skin cancer, spread to lymph nodes that have significant prognostic and therapeutic implications. Fluorescent dyes have long been used in this endeavor. The dye is injected near the primary tumor; fluorescence detection then identifies the first group of nodes to which the lymph travels. These lymph nodes are called sentinel lymph nodes and are biopsied because they are the most likely to have cancer. Therefore, the rising number of cancer cases worldwide and the growing need for early detection are expected to provide growth opportunities for the fluorescent immunoassays market.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the MEA fluorescent immunoassay market at a notable CAGR during the forecast period.

MEA Fluorescent Immunoassay Market Revenue and Forecast to 2028 (US$ Million)

MEA Fluorescent Immunoassay Market Segmentation

The MEA fluorescent immunoassay market is segmented into product type, application, end user, and country. Based on product type, the market is segmented into ELISA, rapid lateral flow immunoassay, and others. The ELISA segment dominated the market in 2021 and is expected to be fastest growing during forecast period. Based on application, the market is segmented into infectious diseases, oncology, cardiovascular diseases, and others. The infectious disease segment dominated the market in 2021 and is expected to be fastest growing during forecast period. Based on end user, the market is segmented into hospitals & clinics, diagnostic centers, pharmaceutical & biotechnology companies, academic & research institutes, and others. The hospitals and clinics segment dominated the market in 2021 and is expected to be fastest growing during forecast period. Based on country, the MEA fluorescent immunoassay market is segmented into South Africa, the UAE, Saudi Arabia, and the Rest of MEA.

Abbott, BD, bioMerieux SA, Danaher, F. Hoffmann-La Roche Ltd., Ortho Clinical Diagnostics Holdings plc, Quidel Corporation, Siemens AG, Sysmex Corporation, and Thermo Fisher Scientific Inc. are among the leading companies operating in the MEA fluorescent immunoassay market.

The List of Companies - Middle East & Africa Fluorescent Immunoassay Market

● Abbott

● BD

● bioMerieux SA

● Danaher

● F. Hoffmann-La Roche Ltd.

● Ortho Clinical Diagnostics Holdings plc

● Quidel Corporation

● Siemens AG

● Sysmex Corporation

● Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 MEA Fluorescent Immunoassay Market – By Product Type

1.3.2 MEA Fluorescent Immunoassay Market – By Application

1.3.3 MEA Fluorescent Immunoassay Market – By End User

1.3.4 MEA Fluorescent Immunoassay Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. MEA Fluorescent Immunoassay Market – Market Landscape

4.1 Overview

4.2 MEA PEST Analysis

4.3 Expert Opinions

5. MEA Fluorescent Immunoassay Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Growing Prevalence of Chronic Diseases

5.1.2 Increasing Demand for Cell Therapies

5.2 Market Restraints

5.2.1 Disadvantages of Fluorescent Immunoassays

5.3 Market Opportunities

5.3.1 Extensive Usage in Cancer Diagnostics

5.4 Future Trends

5.4.1 Increase in Development of Fluorescent Dyes and Instruments

5.5 Impact Analysis

6. Fluorescent Immunoassay Market – MEA Analysis

6.1 MEA Fluorescent Immunoassay Marker Revenue Forecast and Analysis

7. MEA Fluorescent Immunoassay Market Analysis – By Product Type

7.1 Overview

7.2 MEA Fluorescent Immunoassay Market Share by Product Type - 2021 & 2028 (%)

7.3 ELISA

7.3.1 Overview

7.3.2 ELISA: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

7.4 Rapid Lateral Flow Immunoassay

7.4.1 Overview

7.4.2 Rapid Lateral Flow Immunoassay: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

7.5 Others

7.5.1 Overview

7.5.2 Others: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

8. MEA Fluorescent Immunoassay Market Analysis – By Application

8.1 Overview

8.2 MEA Fluorescent Immunoassay Market Share by Application - 2021 & 2028 (%)

8.3 Infectious Diseases

8.3.1 Overview

8.3.2 Infectious Diseases: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

8.4 Oncology

8.4.1 Overview

8.4.2 Oncology: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

8.5 Cardiovascular Disease

8.5.1 Overview

8.5.2 Cardiovascular Disease: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

9. MEA Fluorescent Immunoassay Market Analysis – By End User

9.1 Overview

9.2 MEA Fluorescent Immunoassay Market Share by End User - 2021 & 2028 (%)

9.3 Hospitals & Clinics

9.3.1 Overview

9.3.2 Hospitals & Clinics: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

9.4 Diagnostic Centers

9.4.1 Overview

9.4.2 Diagnostic Centers: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

9.5 Pharmaceutical & Biotechnology Companies

9.5.1 Overview

9.5.2 Pharmaceutical & Biotechnology Companies: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

9.6 Academic & Research Institutes

9.6.1 Overview

9.6.2 Academic & Research Institutes: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

9.7 Others

9.7.1 Overview

9.7.2 Others: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

10. MEA Fluorescent Immunoassay Market Analysis – By Country

10.1 Overview

10.1.1 Middle East & Africa Fluorescent Immunoassay Market, by Country, 2021 & 2028 (%)

10.1.1.1 Saudi Arabia: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.1 Saudi Arabia: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.2 Saudi Arabia Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3 Saudi Arabia Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.4 Saudi Arabia Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.2 UAE: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.1 UAE: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.2 UAE: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.3 UAE: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.4 UAE: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.3 South Africa: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.1 South Africa: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.2 South Africa Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3 South Africa Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.4 South Africa Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.4 Rest of Middle East and Africa: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.1 Rest of Middle East and Africa: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.2 Rest of Middle East & Africa Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.3 Rest of Middle East & Africa: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.4 Rest of Middle East & Africa: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

11. Industry Landscape

11.1 Overview

11.2 Organic Developments

11.2.1 Overview

11.3 Inorganic Developments

11.3.1 Overview

12. Company Profiles

12.1 F. Hoffmann-La Roche Ltd.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Thermo Fisher Scientific Inc.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Abbott

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 BD

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Danaher

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 bioMerieux SA

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Sysmex Corporation

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Siemens AG

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Ortho Clinical Diagnostics Holdings plc

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Quidel Corporation

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About the Insight Partners

13.2 Glossary of Terms

LIST OF TABLES.

Table 1.             MEA Fluorescent Immunoassay Market –Revenue and Forecast to 2028 (USD Million)

Table 2.             Saudi Arabia Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             Saudi Arabia Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)

Table 4.             Saudi Arabia Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)

Table 5.             UAE: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 6.             UAE: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)

Table 7.             UAE: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)

Table 8.             South Africa Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 9.             South Africa Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million

Table 10.          South Africa Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)

Table 11.          Rest of Middle East & Africa: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 12.          Rest of Middle East & Africa: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)

Table 13.          Rest of Middle East & Africa: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)

Table 14.          Organic Developments

Table 15.          Inorganic Developments

Table 16.          Glossary of Terms

The List of Companies - Middle East & Africa Fluorescent Immunoassay Market

● Abbott

● BD

● bioMerieux SA

● Danaher

● F. Hoffmann-La Roche Ltd.

● Ortho Clinical Diagnostics Holdings plc

● Quidel Corporation

● Siemens AG

● Sysmex Corporation

● Thermo Fisher Scientific Inc.

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA fluorescent immunoassay market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the MEA fluorescent immunoassay market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the fluorescent immunoassay market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Middle East & Africa Fluorescent Immunoassay Market Forecast to 2028)
  • Single User Price $3,000$2,400
  • Site Price $4,000$3,200
  • Enterprise Price $5,000$4,000
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry